As of 2024-12-12, the Fair Value of Fulcrum Therapeutics Inc (FULC) is -1.66 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.27 USD, the upside of Fulcrum Therapeutics Inc is -138.89%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -82.68 | -70.82 | -80.85 | -109.87 | -97.33 | -88.31 |
| YoY growth | -153.70% | 14.34% | -14.16% | -35.89% | 11.41% | -35.60% |
| Market Cap (mil) | 230.32 |
| P/E | |
| Forward P/E |
| EPS | -0.33 |
| Avg earnings growth rate | -35.60% |
| TTM earnings | -17.91 |